NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel
Open accessThe DOI matches its Crossref record; 22 of the 23 references it cites were found in a registry or an index.
Abstract
Paclitaxel (PTX) is one of the most effective anticancer agents. In clinical practice, however, high incidences of adverse reactions of the drug, for example, neurotoxicity, myelosuppression, and allergic reactions, have been reported. NK105, a micellar nanoparticle formulation, was developed to overcome these problems and to enhance the antitumour activity of PTX. Via the self-association process, PTX was incorporated into the inner core of the micelle system by physical entrapment through hydrophobic interactions between the drug and the well-designed block copolymers for PTX. NK105 was compared with free PTX with respect to their in vitro cytotoxicity, in vivo antitumour activity, pharmacokinetics, pharmacodynamics, and neurotoxicity. Consequently, the plasma area under the curve (AUC) values were approximately 90-fold higher for NK105 than for free PTX because the leakage of PTX from normal blood vessels was minimal and its capture by the reticuloendothelial system minimised. Thus, the tumour AUC value was 25-fold higher for NK105 than for free PTX. NK105 showed significantly potent antitumour activity on a human colorectal cancer cell line HT-29 xenograft as compared with PTX (P<0.001) because the enhanced accumulation of the drug in the tumour has occurred, probably followed by its effective and sustained release from micellar nanoparticles. Neurotoxicity was significantly weaker with NK105 than with free PTX. The neurotoxicity of PTX was attenuated by NK105, which was demonstrated by both histopathological (P<0.001) and physiological (P<0.05) methods for the first time. The present study suggests that NK105 warrants a clinical trial for patients with metastatic solid tumours.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The size of polymeric micelles currently in clinical trials are less than 100 nm [6, 7].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [7]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“NK105 exhibited 23% of drug loading with a hydrodynamic size of approx. 90 nm [7].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“NK105 is composed of paclitaxel and modified mPEG-b-P(Asp) block copolymer (mPEG = 12,000 g/mol and P(Asp) = 8,000 g/mol) where half of the carboxylic groups P(Asp) block is modified with hydrophobic 4-phenyl-1-butanol to increase its hydrophobicity and improve drug incorporation [7].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Self-citationTumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565 · cited 1×
“Passive targeting is based on the so-called enhanced permeability and retention (EPR) effect (Matsumura and Maeda, 1986; Maeda et al, 2000).”
BackgroundSelf-citationRowinsky, E. K., & Donehower, R. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504133321507 · Cited by 1,924
Hypersensitivity reactions from taxol.
Weiss, R. B., Donehower, R. C., Wiernik, P. H., Ohnuma, T., Gralla, R. J., Trump, D. L., Baker, J. R., Van Echo, D. A., Von Hoff, D. D., & Leyland-Jones, B. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.7.1263 · Cited by 1,174
Micellar Nanocontainers Distribute to Defined Cytoplasmic Organelles
Savić, R., Luo, L., Eisenberg, A., & Maysinger, D. (2003) · Science · doi:10.1126/science.1078192 · Cited by 1,113
Barriers to Drug Delivery in Solid Tumors
Jain, R. K. (1994) · Scientific American · doi:10.1038/scientificamerican0794-58 · Cited by 1,069
Block copolymer micelles as vehicles for drug delivery
Kazunori, K., Glenn S., K., Masayuki, Y., Teruo, O., & Yasuhisa, S. (1993) · Journal of Controlled Release · doi:10.1016/0168-3659(93)90172-2 · Cited by 877
Self-citationKim, T.-Y., Kim, D.-W., Chung, J.-Y., Shin, S. G., Kim, S.-C., Heo, D. S., Kim, N. K., & Bang, Y.-J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0655 · Cited by 821
Ibrahim, N. K., Desai, N. P., Legha, S. S., Soon‐Shiong, P., Theriault, R. L., Rivera, E., Esmaeli, B., Ring, S. E., Bedikian, A. Y., Hortobágyi, G. N., et al. (2002) · PubMed · Cited by 705
Development of the polymer micelle carrier system for doxorubicin
Nakanishi, T., Fukushima, S., Okamoto, K., Suzuki, M., Matsumura, Y., Yokoyama, M., Okano, T., Sakurai, Y., & Kataoka, K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00341-8 · Cited by 570
Self-citation
Research works printed but not linked: 1
- 2. Hamaguchi T, Matsumura Y, Shirao Y, Shimada Y, Yamada Y, Muro Y, Okusaka T, Ueno H, Ikeda M, Watanabe N (2003) Phase I study of novel drug delivery system, NK911, a polymer micelle encapsulated doxor- ubicin. Proc Am Soc Clin Oncol 22: 571
Cited by
Items 401–500 of 565
Nanomedicine Interventions in Clinical Trials for the Treatment of Metastatic Breast Cancer
Moreira, R., Granja, A., Pinheiro, M., & Reis, S. (2021) · Applied Sciences · doi:10.3390/app11041624 · Cited by 12
Wang, L., Fujimoto, K., Yoshii, N., & Okazaki, S. (2016) · The Journal of Chemical Physics · doi:10.1063/1.4940031 · Cited by 10
Exploiting ionisable nature of PEtOx-co-PEI to prepare pH sensitive, doxorubicin-loaded micelles
Öztürk, N., Kara, A., Gülyüz, S., Özköse, U. U., Taşdelen, M. A., Bozkır, A., Yılmaz, Ö., & Vural, İ. (2020) · Journal of Microencapsulation · doi:10.1080/02652048.2020.1792566 · Cited by 10
Abbasi, S., Sato, Y., Kajimoto, K., & Harashima, H. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00542 · Cited by 10
Zhang, Y., Song, H., Zhang, H., Huang, P., Liu, J., Chu, L., Liu, J., Wang, W., Cheng, Z., & Kong, D. (2017) · Journal of Polymer Science Part A Polymer Chemistry · doi:10.1002/pola.28516 · Cited by 10
Spray stability of self-assembled filaments for delivery
Mahmud, A., Harada, T., Rajagopal, K., Christian, D. A., Nair, P. R., Murphy, R., & Discher, D. E. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.05.026 · Cited by 11
Multifunctional core–shell polymeric and hybrid nanoparticles as anticancer nanomedicines
Goračinova, K., Geškovski, N., Dimchevska, S., Li, X., & Gref, R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813669-0.00004-x · Cited by 12
A Snapshot on Polymeric Micelles as a Carrier for Drug Delivery
Agrawal, R., Chauhan, C., & Garg, A. (2023) · Current Nanomedicine · doi:10.2174/2468187313666230320115153 · Cited by 9
Rajput, M. U., Ali, S. W., Kainat, W., Madani, S., & Ding, W. (2025) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2025.114817 · Cited by 11
Nanomaterials targeting cancer stem cells to overcome drug resistance and tumor recurrence
Kumbhakar, D. V., Thakkar, L., Akhand, C., Sharaf, S., & Vemuganti, G. K. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1499283 · Cited by 14
Advances in Polymer Micelles for Cancer Therapy: From Conventional to Smart Delivery Systems
Bryaskova, R. G., Staykov, K., & Ganchev, D. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18020177 · Cited by 11
Nasongkla, N., Nittayacharn, P., Rotjanasitthikit, A., Pungbangkadee, K., & Manaspon, C. (2016) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2016.1163389 · Cited by 9
Sawdon, A. J., Zhang, J., Peng, S., Alyami, E. M., & Peng, C. (2021) · Molecules · doi:10.3390/molecules26061759 · Cited by 10
Kokuryo, D., Aoki, I., Yuba, E., Kono, K., Aoshima, S., Kershaw, J., & Saga, T. (2017) · Translational research · doi:10.1016/j.trsl.2017.04.001 · Cited by 10
Taheri, A., Rad, A., Sadeghi, E., & Varshosaz, J. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200917145551 · Cited by 9
Application of nanocarriers for paclitaxel delivery and chemotherapy of cancer
Malla, S., Neupane, R., Boddu, S. H. S., Abou-Dahech, M. S., Pasternak, M. A., Hussein, N. A., Ashby, C. R., Tang, Y., Babu, R. J., & Tiwari, A. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90951-8.00004-7 · Cited by 10
The Interface of Cancer, Their Microenvironment and Nanotechnology
Roque, N. R., Matias, D., Bal鏰-Silva, J., Ferrer, V. P., Pessoa, L. S., & Spohr, T. C. L. D. S. E. (2022) · ONCOLOGIE · doi:10.32604/oncologie.2022.024035 · Cited by 11
Preparation and characterization of the ion-fixed mixed micelles with superior stability
Yang, L., Fu, Y., Guo, H., Zhang, L., Huang, L., & Yang, L. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.05.011 · Cited by 9
Size Tunable Core Crosslinked Micelles from HPMA‐Based Amphiphilic Block Copolymers
Kramer, S., Kim, K. O., & Zentel, R. (2017) · Macromolecular Chemistry and Physics · doi:10.1002/macp.201700113 · Cited by 9
MacEwan, S. R., & Chilkoti, A. (2017) · Angewandte Chemie · doi:10.1002/ange.201610819 · Cited by 8
The Sojourn of Polymeric Micelles for Effective Brain Drug Delivery System
Kaur, P., Rajput, A., Singh, D., Singh, G., Mehra, A., Kaur, S., Bedi, N., & Arora, S. (2023) · Current Drug Delivery · doi:10.2174/1567201820666230413082352 · Cited by 9
Nano-approaches in cartilage repair.
Giannoni, P., & Narcisi, R. (2009) · PubMed · Cited by 8
Nanotechnology Therapeutics in Oncology—Recent Developments and Future Outlook
Richardson, P. (2012) · Annual reports in medicinal chemistry · doi:10.1016/b978-0-12-396492-2.00016-3 · Cited by 8
Synthesis of Novel bis‐Triazolinedione Crosslinked Amphiphilic Polypept(o)ide Nanostructures
Brannigan, R. P., Kimmins, S. D., Bobbi, E., Caulfield, S., & Heise, A. (2019) · Macromolecular Chemistry and Physics · doi:10.1002/macp.201900067 · Cited by 8
Tang, J., Wang, X.-Q., Wang, T., Chen, F., & Zhou, J. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.09.016 · Cited by 8
Shiraishi, K., Yusa, S., Ito, M., Nakai, K., & Yokoyama, M. (2017) · Polymers · doi:10.3390/polym9120710 · Cited by 10
Self-citationMicellar-Based Nanoparticles for Cancer Therapy and Bioimaging
Andrade, F., Almeida, A., Rafael, D. F. D. S., Schwartz, S., & Sarmento, B. F. C. C. (2018) · Nanomedicine and nanotoxicology · doi:10.1007/978-3-319-89878-0_6 · Cited by 9
Selting, K. A., Axiak‐Bechtel, S. M., Espinosa, J., Henry, C. J., Tate, D. J., Bryan, J. N., Rajewski, L. G., Flesner, B. K., Decedue, C. J., & Baltezor, M. J. (2018) · Veterinary and Comparative Oncology · doi:10.1111/vco.12435 · Cited by 8
Wu, K., Liu, J., lei, L., Shen, Y., & Guo, S. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.09.060 · Cited by 7
Sakai‐Kato, K., Nanjo, K., Kusuhara, H., Nishiyama, N., Kataoka, K., Kawanishi, T., Okuda, H., & Goda, Y. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00234 · Cited by 8
Self-citationAndrade‐Gagnon, B., & Oh, J. K. (2024) · Polymer Chemistry · doi:10.1039/d4py00660g · Cited by 7
Pandey, S. S., Joshi, S., Tripathi, P., Gupta, A. R., & Yadav, J. S. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167956 · Cited by 8
Dwivedi, J., Wal, A., Seemab, M., Singh, A., Wal, P., Tiwari, M., Sharma, K. K., & Gasmi, A. (2026) · Nanomedicine · doi:10.1080/17435889.2026.2698781 · Cited by 10
Das, S., Chakraborty, P., Chakraborty, D. D., & Nath, L. K. (2024) · Biomedical Engineering Advances · doi:10.1016/j.bea.2024.100122 · Cited by 9
Fundamentals of Nanocarriers and Drug Targeting
Shah, D. P. (2021) · Springer eBooks · doi:10.1007/978-981-33-4497-6_1 · Cited by 7
Self‐Folding Macromolecular Drug Carrier for Cancer Imaging and Therapy
Gao, S., Miura, Y., Sumiyoshi, A., Ohno, S., Ogata, K., Nomoto, T., Matsui, M., Honda, Y., Suzuki, M., Iiyama, M., et al. (2023) · Advanced Science · doi:10.1002/advs.202304171 · Cited by 8
Self-citationStealth Engineering for In Vivo Drug Delivery Systems
Mohapatra, A., Morshed, B. I., Haggard, W. O., & Smith, R. A. (2015) · Critical Reviews in Biomedical Engineering · doi:10.1615/critrevbiomedeng.2016016141 · Cited by 8
Novel Nanoprinting for Oral Delivery of Poorly Soluble Drugs
Yılmaz, C., Sarısözen, C., Torchilin, V. P., & BUSNAINA, A. A. (2016) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-12-3-157 · Cited by 7
Theranostic Polymeric Micelles for Cancer Imaging and Therapy
Huang, G., Khemtong, C., Bey, E. A., Boothman, D. A., Sumer, B. D., & Gao, J. (2012) · Nanostructure science and technology · doi:10.1007/978-1-4614-2305-8_12 · Cited by 7
Micellization and Drug Solubility Enhancement Part II: Polymeric Micelles
Liu, R., Forrest, M. L., & Kwon, G. S. (2008) · CRC Press eBooks · doi:10.1201/9781420009552.ch13 · Cited by 9
Drug encapsulation and release behavior of telechelic nanoparticles
Zhang, S., Arshad, M., & Ullah, A. (2015) · Nanotechnology · doi:10.1088/0957-4484/26/41/415703 · Cited by 6
Introduction to biomaterials for cancer therapeutics
Lee, B. K., Yun, Y., Park, K., & Sturek, M. S. (2013) · Elsevier eBooks · doi:10.1533/9780857096760.1.3 · Cited by 9
van Gaal, E. V. B., & Crommelin, D. J. A. (2015) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-319-16241-6_2 · Cited by 12
López-Méndez, T. B., Strippoli, R., Trionfetti, F., Calvo, P., Cordani, M., & González‐Valdivieso, J. (2022) · Springer eBooks · doi:10.1007/978-3-031-17831-3_12 · Cited by 7
Peppas, N. A., Duncan, R., Wnek, G. E., Hoffman, A. S., Gao, G., Kim, S. W., Lee, D. S., Hadjiargyrou, M., Touítou, E., Ainbinder, D., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.034 · Cited by 8
Nanocarriers in Drug and Gene Delivery
Pandita, D., Munjal, A., Godara, S., & Lather, V. (2018) · Springer eBooks · doi:10.1007/978-981-10-4702-2_6 · Cited by 6
Nanomedicine: A Promising Avenue for the Development of Effective Therapy for Breast Cancer
Sartaj, A., Baboota, S., & Ali, J. (2020) · Current Cancer Drug Targets · doi:10.2174/1568009620666200331124113 · Cited by 6
Zhao, T., Zhou, H., Wu, W., Song, X., & Gong, T. (2021) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2021.1879831 · Cited by 7
Yanagihara, K., Kubo, T., Mihara, K., Kuwata, T., Ochiai, A., Seyama, T., & Yokozaki, H. (2019) · Pancreas · doi:10.1097/mpa.0000000000001253 · Cited by 7
Active Targeting Strategies in Cancer with a Focus on Potential Nanotechnology Applications
Mrsny, R. J. (2006) · CRC Press eBooks · doi:10.1201/9781420006636-3 · Cited by 9
Amphiphilic Polymeric Micelle Spherical Nucleic Acids (SNAs) as Drug Delivery Vehicles
Cavaliere, J. P., Forsyth, C. M., Guo, A. X., Kang, J., Ngo, K. H., & Mirkin, C. A. (2025) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5c00507 · Cited by 6
Adaptive Polymers: The pH-Responsive Revolution in Biomedical Materials
Musale, S., Jarande, S. S., Nikam, A., Pawar, R., Kodange, N. N., Kapare, H. S., Nison, M., Pai, V., Aher, A. A., Datta, D., et al. (2026) · ACS Omega · doi:10.1021/acsomega.6c01425 · Cited by 8
Li, Y., Zhong, J., Lu, X., Ming, C., Zhu, H., Ye, G., Yi, W., Xu, C., & Huang, Y. (2024) · Chemistry of Materials · doi:10.1021/acs.chemmater.4c01543 · Cited by 5
Polara, H., Shah, T. V., Babanyinah, G. K., Wang, H., Bhadran, A., Biewer, M. C., & Stefan, M. C. (2025) · Biomacromolecules · doi:10.1021/acs.biomac.5c00280 · Cited by 5
Block copolymer micelles as long-circulating drug delivery vehicles
Abuwatfa, W. H., AlSawaftah, N., & Husseini, G. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89868-3.00023-9 · Cited by 5
Cai, H. X., Ni, C., Yao, B., Zhang, L., & Zhu, C. (2013) · Colloid & Polymer Science · doi:10.1007/s00396-013-3031-9 · Cited by 5
PEO-Modified Poly(L -Amino Acid) Micelles for Drug Delivery
Xiong, X.-B., Aliabadi, H. M., & Lavasanifar, A. (2006) · CRC Press eBooks · doi:10.1201/9781420006636-18 · Cited by 7
Emerging Technologies to Increase the Bioavailability of Poorly Water-Soluble Drugs
Hughey, J. R., & McGinity, J. W. (2011) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-1-4614-1144-4_13 · Cited by 5
Polymeric Micelles for Formulation of Anti-Cancer Drugs
Soo, P. L., Liu, J., Allen, C. J., Lee, H., & Butler, M. (2006) · CRC Press eBooks · doi:10.1201/9781420006636.sec4 · Cited by 6
Polymer Conjugate as the New Promising Drug Delivery System for Combination Therapy against Cancer
Hu, Q., Zhang, Y., Mukerabigwi, J. F., Wang, H., & Cao, Y. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266280603240321064308 · Cited by 6
Dual Trigger Crosslinked Micelles Based Polyamidoamine for Effective Paclitaxel Delivery
Kong, K. V. (2014) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.1000212 · Cited by 4
From Polymers to Nanomedicines: New Materials for Future Vaccines
Heller, P., Huesmann, D., Scherer, M., & Barz, M. (2013) · Springer eBooks · doi:10.1007/978-3-319-00978-0_15 · Cited by 5
Mass spectrometry imaging for early discovery and development of cancer drugs
Yasunaga, M., Manabe, S., Furuta, M., Ogata, K., Koga, Y., Takashima, H., Nishida, T., & Matsumura, Y. (2018) · AIMS Medical Science · doi:10.3934/medsci.2018.2.162 · Cited by 4
Self-citationPolymeric micelles in biomedical science
Bhawani, S. A., Ahmad, F. B., Ibrahim, M. N. M., & Yakout, A. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816504-1.00005-3 · Cited by 6
Chemische Ansätze für synthetische Wirkstofftransportsysteme für systemische Anwendungen
Braatz, D., Cherri, M., Tully, M., Dimde, M., Ma, G., Mohammadifar, E., Reisbeck, F., Ahmadi, V., Schirner, M., & Haag, R. (2022) · Angewandte Chemie · doi:10.1002/ange.202203942 · Cited by 4
Amphiphilic Block Copolymer Based Nanocarriers for Drug and Gene Delivery
Xiong, X.-B., & Lavasanifar, A. (2011) · Fundamental biomedical technologies · doi:10.1007/978-94-007-1248-5_10 · Cited by 5
Nanotechnology Applications in Breast Cancer
Tùng, B. T., Quynh, C. T. X., & Hong, N. K. (2022) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-9258-8.ch020 · Cited by 4
Polymeric Micelles for Cancer‐Targeted Drug Delivery
Chen, H., Ge, Z., & Kataoka, K. (2014) · Wiley eBooks · doi:10.1002/9783527672752.ch4 · Cited by 4
Self-citationModh, H., Leong, D., Dindhoria, K., Malinovskaya, J. A., Pirola, S., Wendt, B., & Wacker, M. G. (2026) · ACS Nano · doi:10.1021/acsnano.6c05350 · Cited by 4
McDaniel, J. R., Bhattacharyya, J., Vargo, K. B., Hassouneh, W., Hammer, D. A., & Chilkoti, A. (2012) · Angewandte Chemie · doi:10.1002/ange.201200899 · Cited by 3
Dorost, P., García‐Alvarez, M., & de Ilarduya, A. M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051377 · Cited by 5
Goel, R., Gulwani, D., Upadhyay, P., Sarangthem, V., & Singh, T. D. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202400332 · Cited by 4
Ultrasonic Drug Delivery Using Micelles and Liposomes
Martins, A. M., Ahmed, S. E., Vítor, R. F., & Husseini, G. A. (2016) · Springer eBooks · doi:10.1007/978-981-287-470-2_29-2 · Cited by 4
Ethylcellulose- An Amazing Polymer For Anticancer Formulations
Mittal, V., Kriplani, P., & Guarve, K. (2023) · Current Applied Polymer Science · doi:10.2174/0124522716273253231129104511 · Cited by 3
Polymeric Micelles for Multiple-Drug Delivery
Kwon, G. S. (2012) · Nanostructure science and technology · doi:10.1007/978-1-4614-2305-8_7 · Cited by 3
Paclitaxel-loaded KMnF3 nanoparticles for cancer imaging and therapy in vivo
Song, X., Wan, H., Zhang, J., & Tang, Q. (2014) · Journal of Nanoparticle Research · doi:10.1007/s11051-014-2722-6 · Cited by 3
Polymeric Nano Micelles as a Drug Carrier
Kim, M. S., Hyun, H., Khang, G., & Lee, H. B. (2009) · Springer eBooks · doi:10.1007/978-3-540-49661-8_16 · Cited by 5
Nanomedicine: Size-Related Drug Delivery Applications, Including Periodontics and Endodontics
Ng, X. W., Mundargi, R. C., & Venkatraman, S. S. (2015) · Springer eBooks · doi:10.1007/978-3-319-13575-5_5 · Cited by 4
Patupilone-loaded poly(L-glutamic acid)-graft-methoxy-poly(ethylene glycol) micelle for oncotherapy
Yan, J., Zhang, D., Yu, H., Ma, L., Deng, M., Tang, Z., & Zhang, X. (2016) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2016.1277827 · Cited by 3
Effects of block copolymer micelles on the pharmacokinetics of encapsulated drugs
Binkhathlan, Z., & Lavasanifar, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816200-2.00017-7 · Cited by 7
Polymeric micelles: Smart nanocarriers for anticancer drug delivery
Raveendran, R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-50922-0.00012-2 · Cited by 5
PEO-Modified Poly(L -Amino Acid) Micelles for Drug Delivery
Xiong, X.-B., Lavasanifar, A., & Aliabadi, H. M. (2006) · CRC Press eBooks · doi:10.1201/9781420006636.ch18 · Cited by 3
Introduction to Nanomedicine and Nanopharmaceuticals
Beus, M., Božičević, L., Mamić, I., Turčić, P., Ventosa, N., González‐Mira, E., & Köber, M. (2024) · Royal Society of Chemistry eBooks · doi:10.1039/9781837672981-00001 · Cited by 4
Wang, R., Zhang, Z., Wang, Q., Gu, P., Yang, Y., Wang, B., & Teng, Y. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s580526 · Cited by 5
Doufène, K., Malki, Y., Vincent, L., Cuq, P., Devoisselle, J., Masurier, N., & Aubert‐Pouëssel, A. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.10.019 · Cited by 2
Cerda-Sumbarda, Y. D., Zizumbo‐López, A., & Licea‐Claveríe, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90390-5.00008-6 · Cited by 3
Dong, Y., Zheng, Y., Zhang, J., Lv, X., Hong, H., Zheng, Y., Wang, R., & Gong, J. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.105101 · Cited by 3
Ray, S., & Singh, D. (2024) · Current Drug Therapy · doi:10.2174/0115748855302263240910060240 · Cited by 3
Global research trends on nanotechnology and colorectal cancer: a two-decade analysis
Mao, X., Li, X., Liu, S., Dong, H., Jia, W., Xu, W., Wu, X., & Zhang, Y. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2452833 · Cited by 2
The initiatives for regulatory science researches of nanomedicines
Harashima, H., Akita, H., Sakai‐Kato, K., Ishii, T., Matsumura, Y., & Kataoka, K. (2014) · Drug Delivery System · doi:10.2745/dds.29.217 · Cited by 2
Self-citationInnovatory role of nanomaterials as bio-tools for treatment of cancer
Ahmad, K. S., Talat, M., Jaffri, S. B., & Shaheen, N. (2020) · Reviews in Inorganic Chemistry · doi:10.1515/revic-2020-0015 · Cited by 2
Synthetic Polymer-based Nanomaterials
Desale, S. S., Zhang, J., & Bronich, T. K. (2015) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-3121-7_1 · Cited by 2
TARGETED NANOTECHNOLOGY FOR ANTICANCER DRUG DELIVERY: CURRENT ISSUE AND CHALLENGE
Kumar, M., & Sharma, H. K. (2018) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v8i5.1882 · Cited by 3
Nanomedicine in Cancer Treatment
Kim, J., & Cho, M. (2014) · Wiley eBooks · doi:10.1002/9781118856017.ch10 · Cited by 2
Multifunctional Polymeric Micelles for Drug Delivery and Therapeutics
Sawdon, A. J., & Peng, C. (2013) · Wiley eBooks · doi:10.1002/9781118636299.ch15 · Cited by 2
Pirraco, R. P., Yamato, M., Akiyama, Y., Nagase, K., Nakayama, M., Marques, A. P., Reis, R. L., & Okano, T. (2012) · Wiley eBooks · doi:10.1002/9781118181249.ch9 · Cited by 2
Natural Product‐Based Nanomedicine
Azahar, N. I., Arifin, M. A., & Mahmood, S. (2025) · Wiley eBooks · doi:10.1002/9781119792192.ch3 · Cited by 2
Stimuli-responsive biopolymeric systems for drug delivery to cancer cells
Seba, V., SILVA, G. H. D. O., Chee, B. S., Henn, J. G., de Lima, G. G., Cao, Z. Q., Marins, M., & Nugent, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821437-4.00014-1 · Cited by 2
Clinical translation of polymeric micelles into market
Raslan, M., Eslam, M. S., Sara, A. R., & Sabri, N. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89868-3.00008-2 · Cited by 1
Sobczak, M., & Kędra-Królik, K. (2026) · Materials · doi:10.3390/ma19142999 · Cited by 1
Metadata
- Authors
- Hamaguchi, T., Matsumura, Y., Suzuki, M., Shimizu, K., Goda, R., Nakamura, I., Nakatomi, I., Yokoyama, M., Kataoka, K., & Kakizoe, T.
- Affiliations
- National Cancer Centre Japan (JP)
- Nippon Kayaku (Japan) (JP)
- NanoCarrier (Japan) (JP)
- Kanagawa Academy of Science and Technology (JP)
- The University of Tokyo (JP)
- Corresponding author
- Matsumura, Y
- Venue
- British Journal of Cancer
- Published
- 2005-03-22
- Volume
- 92
- Issue
- 7
- Pages
- 1240-1246
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- PMC
- PMC2361981
- OpenAlex
- W2112927879
- Cited by
- 565
- References
- 23
- Citations by year
- 2026: 12 · 2025: 17 · 2024: 18 · 2023: 18 · 2022: 23 · 2021: 23 · 2020: 29 · 2019: 21 · 2018: 27 · 2017: 36 · 2016: 41 · 2015: 50 · 2014: 40 · 2013: 29 · 2012: 33
- FWCI
- 10.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- www.springer.com/tdm (unspecified)
- Locations
- British Journal of Cancer (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Oncology › Cancer Treatment and Pharmacology
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- paclitaxel, micellar nanoparticles, nanoparticle drug delivery, neurotoxicity, antitumour activity, pharmacokinetics, pharmacodynamics, block copolymer micelles, colorectal cancer, HT-29 xenograft, drug leakage, sustained drug release, metastatic solid tumors
- MeSH terms
- Animals, Antineoplastic Agents, Phytogenic, Chemistry, Pharmaceutical, Colonic Neoplasms, Humans, Nervous System, Transplantation, Heterologous, Paclitaxel, Area Under Curve, Nanostructures, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.